Developments in magnetic resonance imaging now allow multidimensional assessment of the characteristics of white matter in patients with schizophrenia. Diffusion tensor imaging (DTI), which permits inferences about the coherence of white matter tracts (anisotropy), and magnetization transfer imaging (MTI), which provides a quantitative measure of macromolecular structural integrity, offer complementary views of myelin organization and integrity. Our earlier published research has indicated defects in anisotropy in frontal white matter areas in patients with schizophrenia and pilot data included in this proposal indicate abnormalities using MTI as well. In an extension of these promising results, we will acquire DTI, MTI and structural MRI images with our new 3 Tesla scanner on a new cohort of 60 young first-break schizophrenic patients and 60 chronic schizophrenic patients with a lifespan age range. These patients will be rescanned at the end of the proposal period to provide longitudinal information. A normal comparison group will have similar baseline and follow-up imaging. In addition, a cohort of approximately 120 schizophrenic patients (age 13-60), already scanned at 1.5 Tesla, will receive a clinical follow-up to provide a second independent longitudinal study. We will examine the relationship of these white matter measures to the patients' symptom severity, cognitive performance, and functional status assessed by Core B. We hypothesize that white matter abnormalities will be more marked in the prefrontal and middle temporal than inferior occipital regions. Similarity between DTI and MTI images will be examined statistically. Lastly, we will examine the relationship between choline, myo-inositol, and N-acetylaspartate from spectroscopy studies (Project 5, Chang) and regional white matter DTI and MTI measures from the same regions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
1P50MH066392-01
Application #
6697222
Study Section
Special Emphasis Panel (ZMH1)
Project Start
2002-09-30
Project End
2006-07-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
DUNS #
114400633
City
New York
State
NY
Country
United States
Zip Code
10029
Amiri, Anahita; Coppola, Gianfilippo; Scuderi, Soraya et al. (2018) Transcriptome and epigenome landscape of human cortical development modeled in organoids. Science 362:
Giambartolomei, Claudia; Zhenli Liu, Jimmy; Zhang, Wen et al. (2018) A Bayesian framework for multiple trait colocalization from summary association statistics. Bioinformatics 34:2538-2545
Toker, Lilah; Mancarci, Burak Ogan; Tripathy, Shreejoy et al. (2018) Transcriptomic Evidence for Alterations in Astrocytes and Parvalbumin Interneurons in Subjects With Bipolar Disorder and Schizophrenia. Biol Psychiatry 84:787-796
Huckins, L M; Hatzikotoulas, K; Southam, L et al. (2018) Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa. Mol Psychiatry 23:1169-1180
Wang, Daifeng; Liu, Shuang; Warrell, Jonathan et al. (2018) Comprehensive functional genomic resource and integrative model for the human brain. Science 362:
Mitchell, A C; Javidfar, B; Pothula, V et al. (2018) MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice. Mol Psychiatry 23:123-132
Bryois, Julien; Garrett, Melanie E; Song, Lingyun et al. (2018) Evaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia. Nat Commun 9:3121
Fazio, Leonardo; Pergola, Giulio; Papalino, Marco et al. (2018) Transcriptomic context of DRD1 is associated with prefrontal activity and behavior during working memory. Proc Natl Acad Sci U S A 115:5582-5587
Gusev, Alexander; Mancuso, Nicholas; Won, Hyejung et al. (2018) Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights. Nat Genet 50:538-548
Mitelman, Serge A; Bralet, Marie-Cecile; Mehmet Haznedar, M et al. (2018) Positron emission tomography assessment of cerebral glucose metabolic rates in autism spectrum disorder and schizophrenia. Brain Imaging Behav 12:532-546

Showing the most recent 10 out of 153 publications